Follow
International Journal of Current Microbiology and Applied Sciences (IJCMAS)
IJCMAS is now DOI (CrossRef) registered Research Journal. The DOIs are assigned to all published IJCMAS Articles.
Index Copernicus ICI Journals Master List 2022 - IJCMAS--ICV 2022: 95.28 For more details click here
National Academy of Agricultural Sciences (NAAS) : NAAS Score: *5.38 (2020) [Effective from January 1, 2020] For more details click here

Login as a Reviewer


See Guidelines to Authors
Current Issues
Download Publication Certificate

Original Research Articles                      Volume : 8, Issue:5, May, 2019

PRINT ISSN : 2319-7692
Online ISSN : 2319-7706
Issues : 12 per year
Publisher : Excellent Publishers
Email : editorijcmas@gmail.com /
submit@ijcmas.com
Editor-in-chief: Dr.M.Prakash
Index Copernicus ICV 2018: 95.39
NAAS RATING 2020: 5.38

Int.J.Curr.Microbiol.App.Sci.2019.8(5): 1464-1473
DOI: https://doi.org/10.20546/ijcmas.2019.805.168


Expression of Biomarkers in Canine Mammary Tumours
N. Muniappan*, S. Ramesh, S. Hemalatha, Mohamed Shafiuzama and S.P. Preetha
Department of Veterinary Pharmacology and Toxicology, Madras Veterinary College, Chennai-7, Tamil Nadu Veterinary and Animal Sciences University, India
*Corresponding author
Abstract:

Biomarkers identifiable in tumours have potential use in early diagnosis, staging, prognosis and assessment of response to therapy. This paper describes the immunohistochemical expression of a few reliable biomarkers in post surgical canine mammary gland tumour (CMGT). Immunohistochemical expression of biomarkers in canine mammary tumours was carried out in forty three mammectomised tissue samples. The intensity and distribution of immunostaining of the biomarkers in histological types of CMGT was studied. PCNA showed weak nuclear staining in benign tumour and strong nuclear staining in malignant tumours. Bcl 2 showed weak cytoplasmic staining in benign tumours and moderate cytoplasmic staining in 10-20% of epithelial cells in malignant tumours. Cytokeratin 8/18 expression was strong in >50% of epithelial cells in benign and malignant tumours. Vimentin expression was specific with strong cytoplasmic staining in the stromal fibrous tissue, stromal fusiform cells, myoepithelial cells in tubules, spindle cells, chondroid tissue and lipocytes. CEA expression was negative in benign tumours. Malignant tumours expressed moderate membranous to cytoplasmic staining in 10-20% of luminal epithelial cells. MUC 1 expression was weak membranous staining in <10% of apical portion of luminal epithelial cells in benign tumours. Overexpression of MUC 1 was observed as moderate membranous and cytoplasmic staining in 10-20% of luminal epithelial cells in malignant tumours. HER-2 expression was weak membrane staining in <10% of luminal epithelial cells in benign tumours. Moderate membranous and cytoplasmic staining was observed in 10-20% of luminal epithelial cells in malignant tumours. COX 2 enzyme expression was negative in benign tumours. Moderate cytoplasmic staining in 10-20% of luminal epithelial cells, myoepithelial cells, stromal fusiform cells and stromal inflammatory cells was observed in malignancy. Hence the expression of biomarkers in tissues is of diagnostic and prognostic significance before initiation of treatment regimen in canine mammary tumours.


Keywords: Canine mammary tumours, Biomarkers immnuno histochemistry

Download this article as Download

How to cite this article:

Expression of Biomarkers in Canine Mammary Tumours. 2019. Expression of Biomarkers in Canine Mammary Tumours.Int.J.Curr.Microbiol.App.Sci. 8(5): 1464-1473. doi: https://doi.org/10.20546/ijcmas.2019.805.168
Copyright: This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike license.

Citations